Šalis: Jungtinės Valstijos
kalba: anglų
Šaltinis: NLM (National Library of Medicine)
VERBENA OFFICINALIS (UNII: QT8A71T9BM) (VERBENA OFFICINALIS - UNII:QT8A71T9BM)
DNA Labs, Inc.
SUBLINGUAL
OTC DRUG
Strain, Stress, Tension, over enthusiasm.
unapproved homeopathic
T-31- VERBENA OFFICINALIS SOLUTION DNA LABS, INC. _Disclaimer: This homeopathic product has not been evaluated by the Food and Drug_ _Administration for safety or efficacy. FDA is not aware of scientific evidence to support_ _homeopathy as effective._ ---------- T-31 NDC 58264-0276-1 INDICATIONS Strain, Stress, Tension, over enthusiasm. INGREDIENTS ACTIVE Verbena officinalis 6/8/30x INACTIVE 20% alcohol in purified water. SUGGESTED DOSAGE One dropper under tongue two times daily. Acute symptoms ½ dropper under tongue every 30 minutes for two hours. SHAKE WELL WARNINGS Use only if cap seal is unbroken. If pregnant or breastfeeding, ask a healthcare professional before use. Keep this and all medication out of the reach of children. To be used according to standard homeopathic indications. PRINCIPAL DISPLAY PANEL - 1 FL. OZ. BOTTLE LABEL DYNAMIC NUTRITIONAL ASSOCIATES, INC. T-31 VERVAIN FLOWER ESSENCES 1 FL. OZ. T-31 verbena officinalis solution PRODUCT INFORMATION PRODUCT TYPE HUMAN OTC DRUG ITEM CODE (SOURCE) NDC:58264-0276 ROUTE OF ADMINISTRATION SUBLINGUAL ACTIVE INGREDIENT/ACTIVE MOIETY INGREDIENT NAME BASIS OF STRENGTH STRENGTH VERBENA OFFICINALIS (UNII: QT8A71T9BM) (VERBENA OFFICINALIS - UNII:QT8A71T9BM) VERBENA OFFICINALIS 30 [hp_X] in 1 mL INACTIVE INGREDIENTS INGREDIENT NAME STRENGTH ALCOHOL (UNII: 3K9958V90M) WATER (UNII: 059QF0KO0R) PACKAGING MARKETING START MARKETING END DNA Labs, Inc. # ITEM CODE PACKAGE DESCRIPTION MARKETING START DATE MARKETING END DATE 1 NDC:58264- 0276-1 29.57 mL in 1 BOTTLE, GLASS; Type 0: Not a Combination Product 01/01/1990 MARKETING INFORMATION MARKETING CATEGORY APPLICATION NUMBER OR MONOGRAPH CITATION MARKETING START DATE MARKETING END DATE unapproved homeopathic 01/01/1990 LABELER - DNA Labs, Inc. (031784339) Revised: 5/2022 Perskaitykite visą dokumentą